[Correspondence] Ocular gene therapy for neovascular AMD: a new era? – Authors' reply

Irina Chatziralli and Theodoros Sergentanis note that after intravitreous injection of AAV2-sFLT01, 40% of patients in cohorts 4 and 5 received rescue anti-vascular endothelial growth factor (anti-VEGF) injections.1 They ask for the criteria and implications of rescue injections. They also ask why the presence of subretinal fibrosis was not required in cohort 5.

Source: LANCET - November 10, 2017 Category: General Medicine Authors: Peter A Campochiaro, Jeffrey S Heier, Saleema Kherani, Annaig Le-Halpere, Abraham Scaria Tags: Correspondence Source Type: research